BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

788 related articles for article (PubMed ID: 21253575)

  • 1. Distinct patterns of IFITM-mediated restriction of filoviruses, SARS coronavirus, and influenza A virus.
    Huang IC; Bailey CC; Weyer JL; Radoshitzky SR; Becker MM; Chiang JJ; Brass AL; Ahmed AA; Chi X; Dong L; Longobardi LE; Boltz D; Kuhn JH; Elledge SJ; Bavari S; Denison MR; Choe H; Farzan M
    PLoS Pathog; 2011 Jan; 7(1):e1001258. PubMed ID: 21253575
    [TBL] [Abstract][Full Text] [Related]  

  • 2. IFITM Proteins That Restrict the Early Stages of Respiratory Virus Infection Do Not Influence Late-Stage Replication.
    Meischel T; Fritzlar S; Villalon-Letelier F; Tessema MB; Brooks AG; Reading PC; Londrigan SL
    J Virol; 2021 Sep; 95(20):e0083721. PubMed ID: 34319159
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Identification of Residues Controlling Restriction versus Enhancing Activities of IFITM Proteins on Entry of Human Coronaviruses.
    Zhao X; Sehgal M; Hou Z; Cheng J; Shu S; Wu S; Guo F; Le Marchand SJ; Lin H; Chang J; Guo JT
    J Virol; 2018 Mar; 92(6):. PubMed ID: 29263263
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Duck Interferon-Inducible Transmembrane Protein 3 Mediates Restriction of Influenza Viruses.
    Blyth GA; Chan WF; Webster RG; Magor KE
    J Virol; 2016 Jan; 90(1):103-16. PubMed ID: 26468537
    [TBL] [Abstract][Full Text] [Related]  

  • 5. IFITM proteins inhibit entry driven by the MERS-coronavirus spike protein: evidence for cholesterol-independent mechanisms.
    Wrensch F; Winkler M; Pöhlmann S
    Viruses; 2014 Sep; 6(9):3683-98. PubMed ID: 25256397
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Interferon-Induced Transmembrane Proteins Inhibit Infection by the Kaposi's Sarcoma-Associated Herpesvirus and the Related Rhesus Monkey Rhadinovirus in a Cell-Specific Manner.
    Hörnich BF; Großkopf AK; Dcosta CJ; Schlagowski S; Hahn AS
    mBio; 2021 Dec; 12(6):e0211321. PubMed ID: 34933450
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Interferon-Induced Transmembrane Protein 1 Restricts Replication of Viruses That Enter Cells via the Plasma Membrane.
    Smith SE; Busse DC; Binter S; Weston S; Diaz Soria C; Laksono BM; Clare S; Van Nieuwkoop S; Van den Hoogen BG; Clement M; Marsden M; Humphreys IR; Marsh M; de Swart RL; Wash RS; Tregoning JS; Kellam P
    J Virol; 2019 Mar; 93(6):. PubMed ID: 30567988
    [TBL] [Abstract][Full Text] [Related]  

  • 8. pH Optimum of Hemagglutinin-Mediated Membrane Fusion Determines Sensitivity of Influenza A Viruses to the Interferon-Induced Antiviral State and IFITMs.
    Gerlach T; Hensen L; Matrosovich T; Bergmann J; Winkler M; Peteranderl C; Klenk HD; Weber F; Herold S; Pöhlmann S; Matrosovich M
    J Virol; 2017 Jun; 91(11):. PubMed ID: 28356532
    [TBL] [Abstract][Full Text] [Related]  

  • 9. IFITMs restrict the replication of multiple pathogenic viruses.
    Perreira JM; Chin CR; Feeley EM; Brass AL
    J Mol Biol; 2013 Dec; 425(24):4937-55. PubMed ID: 24076421
    [TBL] [Abstract][Full Text] [Related]  

  • 10. IFITM proteins restrict viral membrane hemifusion.
    Li K; Markosyan RM; Zheng YM; Golfetto O; Bungart B; Li M; Ding S; He Y; Liang C; Lee JC; Gratton E; Cohen FS; Liu SL
    PLoS Pathog; 2013 Jan; 9(1):e1003124. PubMed ID: 23358889
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Role of EXT1 and Glycosaminoglycans in the Early Stage of Filovirus Entry.
    O'Hearn A; Wang M; Cheng H; Lear-Rooney CM; Koning K; Rumschlag-Booms E; Varhegyi E; Olinger G; Rong L
    J Virol; 2015 May; 89(10):5441-9. PubMed ID: 25741008
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Alphavirus Restriction by IFITM Proteins.
    Weston S; Czieso S; White IJ; Smith SE; Wash RS; Diaz-Soria C; Kellam P; Marsh M
    Traffic; 2016 Sep; 17(9):997-1013. PubMed ID: 27219333
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The Polybasic Cleavage Site in SARS-CoV-2 Spike Modulates Viral Sensitivity to Type I Interferon and IFITM2.
    Winstone H; Lista MJ; Reid AC; Bouton C; Pickering S; Galao RP; Kerridge C; Doores KJ; Swanson CM; Neil SJD
    J Virol; 2021 Apr; 95(9):. PubMed ID: 33563656
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Interferon-Induced Transmembrane Protein-Mediated Inhibition of Host Cell Entry of Ebolaviruses.
    Wrensch F; Karsten CB; Gnirß K; Hoffmann M; Lu K; Takada A; Winkler M; Simmons G; Pöhlmann S
    J Infect Dis; 2015 Oct; 212 Suppl 2(Suppl 2):S210-8. PubMed ID: 26034199
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Ebola virus and severe acute respiratory syndrome coronavirus display late cell entry kinetics: evidence that transport to NPC1+ endolysosomes is a rate-defining step.
    Mingo RM; Simmons JA; Shoemaker CJ; Nelson EA; Schornberg KL; D'Souza RS; Casanova JE; White JM
    J Virol; 2015 Mar; 89(5):2931-43. PubMed ID: 25552710
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Opposing activities of IFITM proteins in SARS-CoV-2 infection.
    Shi G; Kenney AD; Kudryashova E; Zani A; Zhang L; Lai KK; Hall-Stoodley L; Robinson RT; Kudryashov DS; Compton AA; Yount JS
    EMBO J; 2021 Feb; 40(3):e106501. PubMed ID: 33270927
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Filoviruses Use the HOPS Complex and UVRAG To Traffic to Niemann-Pick C1 Compartments during Viral Entry.
    Bo Y; Qiu S; Mulloy RP; Côté M
    J Virol; 2020 Jul; 94(16):. PubMed ID: 32493822
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Interferon-induced transmembrane protein 3 blocks fusion of sensitive but not resistant viruses by partitioning into virus-carrying endosomes.
    Suddala KC; Lee CC; Meraner P; Marin M; Markosyan RM; Desai TM; Cohen FS; Brass AL; Melikyan GB
    PLoS Pathog; 2019 Jan; 15(1):e1007532. PubMed ID: 30640957
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Ebola virus triggers receptor tyrosine kinase-dependent signaling to promote the delivery of viral particles to entry-conducive intracellular compartments.
    Stewart CM; Phan A; Bo Y; LeBlond ND; Smith TKT; Laroche G; Giguère PM; Fullerton MD; Pelchat M; Kobasa D; Côté M
    PLoS Pathog; 2021 Jan; 17(1):e1009275. PubMed ID: 33513206
    [TBL] [Abstract][Full Text] [Related]  

  • 20. GILT restricts the cellular entry mediated by the envelope glycoproteins of SARS-CoV, Ebola virus and Lassa fever virus.
    Chen D; Hou Z; Jiang D; Zheng M; Li G; Zhang Y; Li R; Lin H; Chang J; Zeng H; Guo JT; Zhao X
    Emerg Microbes Infect; 2019; 8(1):1511-1523. PubMed ID: 31631785
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 40.